| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83296-100-12 | 83296-100 | HUMAN PRESCRIPTION DRUG | XOLREMDI | mavorixafor | CAPSULE, GELATIN COATED | ORAL | 20240521 | N/A | NDA | NDA218709 | X4 Pharmaceuticals, Inc. | MAVORIXAFOR | 100 mg/1 | 120 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-12) |
| 83296-100-60 | 83296-100 | HUMAN PRESCRIPTION DRUG | XOLREMDI | mavorixafor | CAPSULE, GELATIN COATED | ORAL | 20240521 | N/A | NDA | NDA218709 | X4 Pharmaceuticals, Inc. | MAVORIXAFOR | 100 mg/1 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-60) |
| 83296-100-90 | 83296-100 | HUMAN PRESCRIPTION DRUG | XOLREMDI | mavorixafor | CAPSULE, GELATIN COATED | ORAL | 20241101 | N/A | NDA | NDA218709 | X4 Pharmaceuticals, Inc. | MAVORIXAFOR | 100 mg/1 | 90 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-90) |